Evidence map›Paper›PMID 33228112›Full record

ArticleCancers2020

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers.

Niklas Klümper, Marthe von Danwitz, Johannes Stein, Doris Schmidt, Anja Schmidt, Glen Kristiansen, Michael Muders, Michael Hölzel, Manuel Ritter, Abdullah Alajati and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. DONSON links tumor-cell survival to MIF-associated macrophage remodeling in small cell lung cancer.Apoptosis : an international journal on programmed cell death · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Niklas KlümperDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-3258-0586
Marthe von DanwitzDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Johannes SteinDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Doris SchmidtDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Anja SchmidtDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Glen KristiansenCenter for Integrated Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Michael MudersCenter for Integrated Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Michael HölzelCenter for Integrated Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Manuel RitterDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Abdullah AlajatiDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.
Jörg EllingerDepartment of Urology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-7526-0857
University Hospital Bonn · DE

Funding

Ferdinand Eisenberger grant of the Deutsche Gesellschaft für Urologie (German society of Urology) grant ID KIN1/FE-19
6 · The paper itself

Abstract

Downstream neighbor of Son (DONSON) plays a crucial role in cell cycle progression and in maintaining genomic stability, but its role in prostate cancer (PCa) development and progression is still underinvestigated. Methods: DONSON mRNA expression was analyzed with regard to clinical-pathological parameters and progression using The Cancer Genome Atlas (TCGA) and two publicly available Gene Expression Omnibus (GEO) datasets of PCa. Afterwards, DONSON protein expression was assessed via immunohistochemistry on a comprehensive tissue microarray (TMA). Subsequently, the influence of a DONSON-knockdown induced by the transfection of antisense-oligonucleotides on proliferative capacity and metastatic potential was investigated. DONSON was associated with an aggressive phenotype in the PCa TCGA cohort, two GEO PCa cohorts, and our PCa TMA cohort as DONSON expression was particularly strong in locally advanced, metastasized, and dedifferentiated carcinomas. Thus, DONSON expression was notably upregulated in distant and androgen-deprivation resistant metastases. In vitro, specific DONSON-knockdown significantly reduced the migration capacity in the PCa cell lines PC-3 and LNCaP, which further suggests a tumor-promoting role of DONSON in PCa. In conclusion, the results of our comprehensive expression analyses, as well as the functional data obtained after DONSON-depletion, lead us to the conclusion that DONSON is a promising prognostic biomarker with oncogenic properties in PCa.

Indexed as

biomarkerDONSONDownstream Neighbor of SONmetastatic spreadprostate carcinoma

Identifiers

PMID33228112
PMCPMC7699366
OpenAlexW3103624268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.